1. Cartwright T, Endean N, Porter A. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol. 2009. 160:1034–1039.
Article
2. van der Donk J, Passchier J, Dutree-Meulenberg RO, Stolz E, Verhage F. Psychologic characteristics of men with alopecia androgenetica and their modification. Int J Dermatol. 1991. 30:22–28.
Article
3. Maffei C, Fossati A, Rinaldi F, Riva E. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol. 1994. 130:868–872.
Article
4. Rushton DH. Androgenetic alopecia in men: the scale of the problem and prospects for treatment. Int J Clin Pract. 1999. 53:50–53.
5. Passchier J. Quality of life issues in male pattern hair loss. Dermatology. 1998. 197:217–218.
Article
6. Girman CJ, Rhodes T, Lilly FR, Guo SS, Siervogel RM, Patrick DL, et al. Effects of self-perceived hair loss in a community sample of men. Dermatology. 1998. 197:223–229.
Article
7. Reid EE, Haley AC, Borovicka JH, Rademaker A, West DP, Colavincenzo M, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol. 2012. 66:e97–e102.
Article
8. Prinsen CA, Lindeboom R, Sprangers MA, Legierse CM, de Korte J. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol. 2010. 130:1318–1322.
Article
9. Lee WS, Ro BI, Hong SP, Bak H, Sim WY, Kim do W, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification. J Am Acad Dermatol. 2007. 57:37–46.
Article
10. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997. 133:1433–1440.
Article
11. Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999. 141:398–405.
Article
12. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol. 2001. 144:1038–1043.
Article
13. Fischer TW, Schmidt S, Strauss B, Elsner P. Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases. Hautarzt. 2001. 52:219–227.
14. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001. 5:105–110.
Article
15. Kim HJ, Sim WY, Song JY. Assessment of the characteristics of illness behavior and quality of life in patients with androgenetic alopecia. Korean J Dermatol. 2001. 39:1094–1099.
16. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol. 1992. 26:926–931.
Article
17. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for androgenetic alopecia. J Am Acad Dermatol. 1996. 35:465–468.
Article
18. Price VH. Androgenetic alopecia in adolescents. Cutis. 2003. 71:115–121.